<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:48:16Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9978954" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9978954</identifier>
        <datestamp>2023-03-03</datestamp>
        <setSpec>jamasd</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id>
              <journal-title-group>
                <journal-title>JAMA Network Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2574-3805</issn>
              <publisher>
                <publisher-name>American Medical Association</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9978954</article-id>
              <article-id pub-id-type="pmcid">PMC9978954</article-id>
              <article-id pub-id-type="pmc-uid">9978954</article-id>
              <article-id pub-id-type="pmid">36857053</article-id>
              <article-id pub-id-type="pmid">36857053</article-id>
              <article-id pub-id-type="doi">10.1001/jamanetworkopen.2023.1055</article-id>
              <article-id pub-id-type="publisher-id">zoi230061</article-id>
              <article-categories>
                <subj-group subj-group-type="category" specific-use="electronic">
                  <subject>Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Investigation</subject>
                </subj-group>
                <subj-group subj-group-type="online-only">
                  <subject>Online Only</subject>
                </subj-group>
                <subj-group subj-group-type="subject-area">
                  <subject>Neurology</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers</article-title>
                <subtitle>Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial</subtitle>
                <alt-title alt-title-type="headline">Blood Pressure Control and Changes in Cerebral Small Vessel Disease Biomarkers</alt-title>
                <alt-title alt-title-type="running-head">Blood Pressure Control and Changes in Cerebral Small Vessel Disease Biomarkers</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rashid</surname>
                    <given-names>Tanweer</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Karl</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Toledo</surname>
                    <given-names>Jon B.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="zoi230061aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nasrallah</surname>
                    <given-names>Ilya</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <xref rid="zoi230061aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pajewski</surname>
                    <given-names>Nicholas M.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff6" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dolui</surname>
                    <given-names>Sudipto</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Detre</surname>
                    <given-names>John</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi230061aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <xref rid="zoi230061aff7" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wolk</surname>
                    <given-names>David A.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi230061aff7" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Liu</surname>
                    <given-names>Hangfan</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Heckbert</surname>
                    <given-names>Susan R.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff8" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bryan</surname>
                    <given-names>R. Nick</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Williamson</surname>
                    <given-names>Jeff</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi230061aff9" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Davatzikos</surname>
                    <given-names>Christos</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <xref rid="zoi230061aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Seshadri</surname>
                    <given-names>Sudha</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi230061aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Launer</surname>
                    <given-names>Lenore J.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff10" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Habes</surname>
                    <given-names>Mohamad</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi230061aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="zoi230061aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="zoi230061aff1"><label>1</label>Neuroimage Analytics Laboratory and the Biggs Institute Neuroimaging Core, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, University of Texas Health Science Center San Antonio, San Antonio</aff>
              <aff id="zoi230061aff2"><label>2</label>Department of Neurology, University of Florida, Gainesville</aff>
              <aff id="zoi230061aff3"><label>3</label>Department of Neurology, Houston Methodist Hospital, Houston, Texas</aff>
              <aff id="zoi230061aff4"><label>4</label>Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia</aff>
              <aff id="zoi230061aff5"><label>5</label>Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia</aff>
              <aff id="zoi230061aff6"><label>6</label>Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina</aff>
              <aff id="zoi230061aff7"><label>7</label>Department of Neurology, University of Pennsylvania, Philadelphia</aff>
              <aff id="zoi230061aff8"><label>8</label>Department of Epidemiology, University of Washington, Seattle</aff>
              <aff id="zoi230061aff9"><label>9</label>Section of Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina</aff>
              <aff id="zoi230061aff10"><label>10</label>Intramural Research Program, Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Bethesda, Maryland</aff>
              <author-notes>
                <title>Article Information</title>
                <p><bold>Accepted for Publication:</bold> January 13, 2023.</p>
                <p content-type="published-online"><bold>Published:</bold> March 1, 2023. <?xpp bx;1?>doi:<uri content-type="doi">10.1001/jamanetworkopen.2023.1055</uri></p>
                <p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. © 2023 Rashid T et al. <italic>JAMA Network Open</italic>.</p>
                <corresp id="zoi230061cor1"><bold>Corresponding Author:</bold> Mohamad Habes, PhD, Neuroimage Analytics Laboratory and the Biggs Institute Neuroimaging Core, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 (<email xlink:href="habes@uthscsa.edu">habes@uthscsa.edu</email>).</corresp>
                <p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Rashid and Habes had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Launer and Habes contributed equally to this work.</p>
                <p><italic>Concept and design:</italic> Rashid, Nasrallah, Pajewski, Bryan, Williamson, Seshadri, Launer, Habes.</p>
                <p><italic>Acquisition, analysis, or interpretation of data:</italic> Rashid, Li, Toledo, Nasrallah, Pajewski, Dolui, Detre, Wolk, Liu, Heckbert, Bryan, Williamson, Davatzikos, Habes.</p>
                <p><italic>Drafting of the manuscript:</italic> Rashid, Li, Habes.</p>
                <p><italic>Critical revision of the manuscript for important intellectual content:</italic> All authors.</p>
                <p><italic>Statistical analysis:</italic> Rashid, Li, Toledo, Pajewski, Habes.</p>
                <p><italic>Obtained funding:</italic> Bryan, Williamson, Seshadri, Launer, Habes.</p>
                <p><italic>Administrative, technical, or material support:</italic> Nasrallah, Pajewski, Dolui, Detre, Liu, Bryan, Williamson, Seshadri, Habes.</p>
                <p><italic>Supervision:</italic> Toledo, Nasrallah, Pajewski, Bryan, Habes.</p>
                <p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Toledo reported serving as a consultant for Acamar Partners. Dr Pajewski reported receiving grants from the Alzheimer’s Association during the conduct of the study. Dr Wolk reported receiving grants from Biogen and Eli Lilly; and personal fees from Qynapse, GE Healthcare, and Functional Neuromodulation outside the submitted work. Dr Williamson reported receiving grants from Biogen outside the submitted work. Dr Seshadri reported receiving personal fees from Biogen and Eisai outside the submitted work. No other disclosures were reported.</p>
                <p content-type="funding-statement"><bold>Funding/Support:</bold> This study was supported in part by grants 1R01AG080821, P30AG066546, and 1U24AG074855 and contract 75N95020P00344 from the National Institues of Health (NIH); grants 5R01HL127659 and 1U24AG074855 from the South Texas Alzheimer’s Disease Research Center; and grant 1000003860 from the San Antonio Medical Foundation. Dr Toledo is supported by the Edmond J. Safra Fellowship in Movement Disorders. Dr Pajewski is supported by grants R01AG055606 and R01AG065805 from the National Institute on Aging (NIA). The Systolic Blood Pressure Intervention Trial was funded by contracts HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C and interagency agreement A-HL-13-002-001 from the NIH (including the National Heart, Lung, and Blood Institute; the National Institute of Diabetes and Digestive and Kidney Diseases; the NIA; and the National Institute of Neurological Disorders and Stroke). It was also supported in part with resources and use of facilities through the US Department of Veterans Affairs. Azilsartan and chlorthalidone (combined with azilsartan) were provided by Takeda Pharmaceuticals International Inc. Computing resources were supported through grant 1S10OD023495-01 from the NIH and additional support was provided through the following National Center for Advancing Translational Sciences clinical and translational science awards: UL1TR000439 (awarded to Case Western Reserve University); UL1RR025755 (awarded to The Ohio State University); UL1RR024134 and UL1TR000003 (awarded to University of Pennsylvania); UL1RR025771 (awarded to Boston University); UL1TR000093 (awarded to Stanford University); UL1RR025752, UL1TR000073, and UL1TR001064 (awarded to Tufts University); UL1TR000050 (awarded to University of Illinois); UL1TR000005 (awarded to University of Pittsburgh); 9U54TR000017-06 (awarded to University of Texas Southwestern Medical Center); UL1TR000105-05 (awarded to University of Utah); UL1TR000445 (awarded to Vanderbilt University); UL1TR000075 (awarded to George Washington University); UL1TR000002 (awarded to University of California, Davis); UL1TR000064 (awarded to University of Florida); and UL1TR000433 (awarded to University of Michigan); and by the National Institute of General Medical Sciences, Centers of Biomedical Research Excellence award NIGMS P30GM103337 (awarded to Tulane University).</p>
                <p><bold>Role of the Funder/Sponsor:</bold> The NIH and the US Department of Veterans Affairs had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; but not in the decision to submit the manuscript for publication. Takeda Pharmaceuticals did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.</p>
                <p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 3</xref>.</p>
              </author-notes>
              <pub-date pub-type="epub" iso-8601-date="2023-03-01T10:00">
                <day>1</day>
                <month>3</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>3</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>1</day>
                <month>3</month>
                <year>2023</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>6</volume>
              <issue>3</issue>
              <elocation-id>e231055</elocation-id>
              <history>
                <date date-type="received">
                  <day>23</day>
                  <month>8</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>13</day>
                  <month>1</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright 2023 Rashid T et al. <italic>JAMA Network Open</italic>.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf-version" xlink:href="jamanetwopen-e231055.pdf">jamanetwopen-e231055.pdf</self-uri>
              <self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.1055"/>
              <abstract abstract-type="key-points">
                <title>Key Points</title>
                <sec id="ab-zoi230061-1">
                  <title>Question</title>
                  <p>How is intensive vs standard blood pressure treatment associated with small vessel disease biomarkers, such as white matter lesions, fractional anisotropy, mean diffusivity, and cerebral blood flow?</p>
                </sec>
                <sec id="ab-zoi230061-2">
                  <title>Findings</title>
                  <p>In this post hoc analysis of a randomized clinical trial with 458 participants, intensive blood pressure treatment was associated with reduced progression of white matter lesions, notably in deep white matter tracts, and supported by corresponding changes in fractional anisotropy and mean diffusivity. Intensive blood pressure treatment was also associated with improved cerebral blood flow in the occipital lobe, parietal lobule, frontal gyrus, and cuneus.</p>
                </sec>
                <sec id="ab-zoi230061-3">
                  <title>Meaning</title>
                  <p>Findings suggest that intensive blood pressure treatment was associated with a slower increase of white matter lesions and improved cerebral blood flow in areas that may be vulnerable to hypertension.</p>
                </sec>
              </abstract>
              <abstract>
                <sec id="ab-zoi230061-4">
                  <title>Importance</title>
                  <p>Little is known about the associations of strict blood pressure (BP) control with microstructural changes in small vessel disease markers.</p>
                </sec>
                <sec id="ab-zoi230061-5">
                  <title>Objective</title>
                  <p>To investigate the regional associations of intensive vs standard BP control with small vessel disease biomarkers, such as white matter lesions (WMLs), fractional anisotropy (FA), mean diffusivity (MD), and cerebral blood flow (CBF).</p>
                </sec>
                <sec id="ab-zoi230061-6">
                  <title>Design, Setting, and Participants</title>
                  <p>The Systolic Blood Pressure Intervention Trial (SPRINT) is a multicenter randomized clinical trial that compared intensive systolic BP (SBP) control (SBP target &lt;120 mm Hg) vs standard control (SBP target &lt;140 mm Hg) among participants aged 50 years or older with hypertension and without diabetes or a history of stroke. The study began randomization on November 8, 2010, and stopped July 1, 2016, with a follow-up duration of approximately 4 years. A total of 670 and 458 participants completed brain magnetic resonance imaging at baseline and follow-up, respectively, and comprise the cohort for this post hoc analysis. Statistical analyses for this post hoc analysis were performed between August 2020 and October 2022.</p>
                </sec>
                <sec id="ab-zoi230061-7">
                  <title>Interventions</title>
                  <p>At baseline, 355 participants received intensive SBP treatment and 315 participants received standard SBP treatment.</p>
                </sec>
                <sec id="ab-zoi230061-8">
                  <title>Main Outcomes and Measures</title>
                  <p>The main outcomes were regional changes in WMLs, FA, MD (in white matter regions of interest), and CBF (in gray matter regions of interest).</p>
                </sec>
                <sec id="ab-zoi230061-9">
                  <title>Results</title>
                  <p>At baseline, 355 participants (mean [SD] age, 67.7 [8.0] years; 200 men [56.3%]) received intensive BP treatment and 315 participants (mean [SD] age, 67.0 [8.4] years; 199 men [63.2%]) received standard BP treatment. Intensive treatment was associated with smaller mean increases in WML volume compared with standard treatment (644.5 mm<sup>3</sup> vs 1258.1 mm<sup>3</sup>). The smaller mean increases were observed specifically in the deep white matter regions of the left anterior corona radiata (intensive treatment, 30.3 mm<sup>3</sup> [95% CI, 16.0-44.5 mm<sup>3</sup>]; standard treatment, 80.5 mm<sup>3</sup> [95% CI, 53.8-107.2 mm<sup>3</sup>]), left tapetum (intensive treatment, 11.8 mm<sup>3</sup> [95% CI, 4.4-19.2 mm<sup>3</sup>]; standard treatment, 27.2 mm<sup>3</sup> [95% CI, 19.4-35.0 mm<sup>3</sup>]), left superior fronto-occipital fasciculus (intensive treatment, 3.2 mm<sup>3</sup> [95% CI, 0.7-5.8 mm<sup>3</sup>]; standard treatment, 9.4 mm<sup>3</sup> [95% CI, 5.5-13.4 mm<sup>3</sup>]), left posterior corona radiata (intensive treatment, 26.0 mm<sup>3</sup> [95% CI, 12.9-39.1 mm<sup>3</sup>]; standard treatment, 52.3 mm<sup>3</sup> [95% CI, 34.8-69.8 mm<sup>3</sup>]), left splenium of the corpus callosum (intensive treatment, 45.4 mm<sup>3</sup> [95% CI, 25.1-65.7 mm<sup>3</sup>]; standard treatment, 83.0 mm<sup>3</sup> [95% CI, 58.7-107.2 mm<sup>3</sup>]), left posterior thalamic radiation (intensive treatment, 53.0 mm<sup>3</sup> [95% CI, 29.8-76.2 mm<sup>3</sup>]; standard treatment, 106.9 mm<sup>3</sup> [95% CI, 73.4-140.3 mm<sup>3</sup>]), and right posterior thalamic radiation (intensive treatment, 49.5 mm<sup>3</sup> [95% CI, 24.3-74.7 mm<sup>3</sup>]; standard treatment, 102.6 mm<sup>3</sup> [95% CI, 71.0-134.2 mm<sup>3</sup>]).</p>
                </sec>
                <sec id="ab-zoi230061-10">
                  <title>Conclusions and Relevance</title>
                  <p>This study suggests that intensive BP treatment, compared with standard treatment, was associated with a slower increase of WMLs, improved diffusion tensor imaging, and FA and CBF changes in several brain regions that represent vulnerable areas that may benefit from more strict BP control.</p>
                </sec>
                <sec id="ab-zoi230061-11">
                  <title>Trial Registration</title>
                  <p>ClinicalTrials.gov Identifier: <ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT01206062" ext-link-type="uri">NCT01206062</ext-link></p>
                </sec>
              </abstract>
              <abstract abstract-type="teaser" specific-use="electronic">
                <p>This post hoc secondary analysis of the SPRINT MIND randomized clinical trial investigates the regional associations of intensive vs standard blood pressure control with small vessel disease biomarkers, such as white matter lesions, fractional anisotropy, mean diffusivity, and cerebral blood flow.</p>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec id="H1-1-ZOI230061">
              <title>Introduction</title>
              <p>Hypertension is a major risk factor for cardiovascular disease and stroke,<sup><xref rid="zoi230061r1" ref-type="bibr">1</xref></sup> with a 45.6% prevalence among US adults and an annual cost of $52 billion.<sup><xref rid="zoi230061r2" ref-type="bibr">2</xref></sup> Clinical trials studying the efficacy of antihypertensive drugs have demonstrated a decrease in the incidence of cardiovascular disease, stroke, myocardial infarction, and heart failure associated with these agents.<sup><xref rid="zoi230061r3" ref-type="bibr">3</xref></sup> Small vessel disease and hypertension-related changes can be seen primarily in T2-weighted or fluid-attenuated inversion recovery sequences manifesting as white matter lesions (WMLs)<sup><xref rid="zoi230061r4" ref-type="bibr">4</xref>,<xref rid="zoi230061r5" ref-type="bibr">5</xref>,<xref rid="zoi230061r6" ref-type="bibr">6</xref></sup> or in diffusion tensor imaging (DTI) sequences as disruption or damage of fiber tracts.<sup><xref rid="zoi230061r7" ref-type="bibr">7</xref>,<xref rid="zoi230061r8" ref-type="bibr">8</xref>,<xref rid="zoi230061r9" ref-type="bibr">9</xref>,<xref rid="zoi230061r10" ref-type="bibr">10</xref></sup> These changes can also be associated with Alzheimer disease, non–Alzheimer disease cognitive impairment, and advanced brain aging.<sup><xref rid="zoi230061r4" ref-type="bibr">4</xref>,<xref rid="zoi230061r11" ref-type="bibr">11</xref>,<xref rid="zoi230061r12" ref-type="bibr">12</xref></sup> Through midlife, the WML burden is greater in the frontal regions, while most parietotemporal WML burdens develop primarily after the sixth decade of life.<sup><xref rid="zoi230061r11" ref-type="bibr">11</xref></sup> Neuroimaging and histopathologic studies suggest that frontal lesions have a more vascular origin, while parietotemporal WMLs are more closely associated with neurodegenerative disease–related changes.<sup><xref rid="zoi230061r10" ref-type="bibr">10</xref>,<xref rid="zoi230061r13" ref-type="bibr">13</xref>,<xref rid="zoi230061r14" ref-type="bibr">14</xref>,<xref rid="zoi230061r15" ref-type="bibr">15</xref>,<xref rid="zoi230061r16" ref-type="bibr">16</xref>,<xref rid="zoi230061r17" ref-type="bibr">17</xref></sup></p>
              <p>Fractional anisotropy (FA) and mean diffusivity (MD) are quantitative metrics calculated from diffusion magnetic resonance imaging (MRI). Fractional anisotropy describes the directional coherence of water diffusion in tissue and is generally interpreted as a quantitative biomarker for white matter (WM) integrity, while MD describes the overall diffusion of water molecules and typically has a low value in WM.<sup><xref rid="zoi230061r18" ref-type="bibr">18</xref></sup> Cerebral blood flow (CBF), calculated<sup><xref rid="zoi230061r19" ref-type="bibr">19</xref>,<xref rid="zoi230061r20" ref-type="bibr">20</xref></sup> from arterial spin labeling MRI, is a relative measure of the volume of blood flowing through tissue over time.</p>
              <p>Previous randomized, prospective trials with few participants and a brief trial duration have assessed the effect of blood pressure (BP) control on cerebral perfusion, with mixed findings.<sup><xref rid="zoi230061r21" ref-type="bibr">21</xref>,<xref rid="zoi230061r22" ref-type="bibr">22</xref>,<xref rid="zoi230061r23" ref-type="bibr">23</xref></sup> Large-scale clinical trials with multimodal imaging are therefore essential to report robust findings on the precise improvement of brain regions with intensive hypertension treatment, which could explain brain reserve and cognition maintenance.</p>
              <p>We hypothesized that antihypertensive treatment would be associated with protection of frontal brain regions. Toward that, we compared regional WML changes throughout the brain between a group receiving intensive BP control and a group receiving standard BP control. We further characterized the nature of the WM microstructural changes using regional DTI analysis and investigated as a secondary hypothesis that intensive hypertension management would be associated with regional improvement in CBF. We used the Systolic Blood Pressure Intervention Trial (SPRINT) Memory and Cognition in Decreased Hypertension (MIND) clinical trial, which is a large-scale multisite landmark study that demonstrated improved cognition and brain reserve in the group that received intensive systolic BP (SBP) control. We expand on previous reports<sup><xref rid="zoi230061r24" ref-type="bibr">24</xref>,<xref rid="zoi230061r25" ref-type="bibr">25</xref>,<xref rid="zoi230061r26" ref-type="bibr">26</xref>,<xref rid="zoi230061r27" ref-type="bibr">27</xref>,<xref rid="zoi230061r28" ref-type="bibr">28</xref></sup> demonstrating the regional changes in WM integrity and CBF that may be associated with hypertension control.</p>
            </sec>
            <sec id="H1-2-ZOI230061">
              <title>Methods</title>
              <sec id="H2-1-ZOI230061">
                <title>Trial Design</title>
                <p>The SPRINT trial was designed to examine the effects of intensive SBP control vs standard SBP control on cardiovascular disease as the primary outcome and kidney function, dementia or decline in cognitive function, and small-vessel cerebral ischemic disease as secondary outcomes, as previously described.<sup><xref rid="zoi230061r24" ref-type="bibr">24</xref>,<xref rid="zoi230061r29" ref-type="bibr">29</xref></sup> The trial and substudies were approved by the institutional review board of each participating site (University of Alabama at Birmingham, Boston University, Vanderbilt University, Wake Forest University, University of Miami, University of Pennsylvania, and Case Western Reserve University), and each participant provided written informed consent. Enrollment began on November 8, 2010, and ended July 1, 2016. The trial protocol is provided in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 1</xref>. Additional details regarding the SPRINT trial design can be found in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 1</xref>. This study was conducted in accordance with the Consolidated Standards of Reporting Trials (<ext-link xlink:href="http://www.equator-network.org/reporting-guidelines/consort/" ext-link-type="uri">CONSORT</ext-link>) reporting guideline.</p>
              </sec>
              <sec id="H2-2-ZOI230061">
                <title>Study Participants</title>
                <p>A total of 9361 participants were randomized to receive either a standard treatment strategy with a target SBP of less than 140 mm Hg (n = 4683) or an intensive treatment strategy with a target SBP of less than 120 mm Hg (n = 4678). Additional details on participants are provided in the trial protocol in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 1</xref>.</p>
                <p>Race was self-reported by participants as Black, Hispanic, White, and other (Asian, American Indian or Native Alaskan, Native Hawaiian or Pacific Islander, or other races). Black race includes Hispanic Black and Black as part of multiracial identification. Hispanic race and ethnicity encompasses a self-report of being of Spanish, Hispanic, or Latino origin, independent of any other race and ethnicity designation.</p>
              </sec>
              <sec id="H2-3-ZOI230061">
                <title>Analytical Sample</title>
                <p>Of the 9361 randomized participants, 2921 were selected for a post hoc substudy of cognitive outcomes<sup><xref rid="zoi230061r30" ref-type="bibr">30</xref></sup> and were administered a comprehensive cognitive battery at baseline and follow-up. Of these, 1267 participants were invited to participate in the post hoc SPRINT MIND substudy to undergo brain MRI scanning at baseline and 48-month follow-up at 1 of 7 designated MRI sites (<xref rid="zoi230061f1" ref-type="fig">Figure 1</xref>). Inclusion and exclusion criteria for participants in the MRI substudy are discussed in the trial protocol in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 1</xref>.</p>
                <fig position="float" id="zoi230061f1" fig-type="figure">
                  <label>Figure 1. </label>
                  <caption>
                    <title>Flow Diagram Showing the Randomization Eligibility, Inclusion, and Exclusion of the Participants for the Magnetic Resonance Imaging (MRI) Substudy</title>
                    <p>CBF indicates cerebral blood flow; DTI, diffusion tensor imaging; FA, fractional anisotropy; FLAIR, fluid-attenuated inversion recovery; MD, mean diffusivity; SBP, systolic blood pressure; and WMLs, white matter lesions.</p>
                    <p><sup>a</sup>Other reasons for unwillingness to participate include participant could not lie flat for extended periods (n = 7), participant reported metal in body before formal screening (n = 8), participant concerns about stent or other cardiac device (n = 8), concerns about body size (n = 2), other reasons (n = 7), and unknown reason (n = 22).</p>
                    <p><sup>b</sup>Other reasons for ineligibility include participant concerns about stent or other cardiac device (n = 8), use of pain pump (n = 2), prolonged hospitalization (n = 2), participant declined consent (n = 2), participant too large for MRI scanner (n = 1), and other reasons (n = 7).</p>
                  </caption>
                  <graphic xlink:href="jamanetwopen-e231055-g001" position="float"/>
                </fig>
              </sec>
              <sec id="H2-4-ZOI230061">
                <title>Magnetic Resonance Imaging</title>
                <p>The SPRINT MIND study acquired brain MRI scans of participants at baseline and 48-month follow-up after randomization. Imaging parameters are detailed in eTable 1 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>. All image analysts were blinded to treatment group. We worked with the same WML segmentations used in previous SPRINT studies.<sup><xref rid="zoi230061r26" ref-type="bibr">26</xref>,<xref rid="zoi230061r27" ref-type="bibr">27</xref>,<xref rid="zoi230061r28" ref-type="bibr">28</xref></sup> These WML segmentations were derived with a deep learning method<sup><xref rid="zoi230061r31" ref-type="bibr">31</xref></sup> and applied in large cohort studies<sup><xref rid="zoi230061r11" ref-type="bibr">11</xref>,<xref rid="zoi230061r32" ref-type="bibr">32</xref>,<xref rid="zoi230061r33" ref-type="bibr">33</xref>,<xref rid="zoi230061r34" ref-type="bibr">34</xref></sup> with similar settings. We calculated the total WMLs, mean FA, and MD for all the WM regions of interest (ROIs) of the Type III WM parcellation map.<sup><xref rid="zoi230061r35" ref-type="bibr">35</xref></sup> The WM delineations of the Type III WM parcellation map atlas were described as highly likely to be WM with minimum contamination from gray matter (GM) and cerebrospinal fluid.<sup><xref rid="zoi230061r35" ref-type="bibr">35</xref></sup> In the case of FA and MD, we calculated the mean in only WM ROIs because water diffusion is more anisotropic in these regions than in GM and cerebrospinal fluid.<sup><xref rid="zoi230061r36" ref-type="bibr">36</xref>,<xref rid="zoi230061r37" ref-type="bibr">37</xref></sup> The mean cerebrospinal fluid was calculated for GM ROIs only because the signal in these regions tends to be more reliable and stronger<sup><xref rid="zoi230061r38" ref-type="bibr">38</xref>,<xref rid="zoi230061r39" ref-type="bibr">39</xref></sup> than in WM ROIs.<sup><xref rid="zoi230061r40" ref-type="bibr">40</xref></sup> Detailed descriptions on WML, FA, MD, and CBF calculations are provided in eMethods 1 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>. Thirteen participants with baseline MRI scans had structural brain lesions and 3 participants at follow-up had large strokes; these participants were excluded from the analysis.</p>
              </sec>
              <sec id="H2-5-ZOI230061">
                <title>Statistical Analysis</title>
                <p>Statistical analyses were performed between August 2020 and October 2022. We used linear mixed-effects models to estimate changes in MRI measures (FA, MD, WMLs, and CBF) for the treatment groups, with participant and MRI facility treated as random intercepts. Treatment group, intracranial volume, age, sex, and time since randomization (in days) were treated as fixed effects. For WMLs, an inverse hyperbolic sine transform—asinh: <italic>f</italic>(<italic>x</italic>) = log [<italic>x</italic> + (<italic>x</italic><sup>2</sup> + 1)<sup>0.5</sup>]—was used to accommodate zero values.<sup><xref rid="zoi230061r41" ref-type="bibr">41</xref></sup></p>
                <p>All statistical analyses were performed using R, version 3.6 (R Group for Statistical Computing).<sup><xref rid="zoi230061r42" ref-type="bibr">42</xref></sup> All hypothesis tests were 2-sided, and <italic>P</italic> &lt; .05 was considered statistically significant. <italic>P</italic> values, uncorrected and after adjustments for multiple comparisons (with false discovery rate, Benjamini and Hochberg method<sup><xref rid="zoi230061r43" ref-type="bibr">43</xref></sup>]), are reported in eTables 4 to 10 and eTable 12 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>. <xref rid="zoi230061f2" ref-type="fig">Figure 2</xref>, <xref rid="zoi230061f3" ref-type="fig">Figure 3</xref>, and the eFigure in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref> show all ROIs with significant <italic>P</italic> values (uncorrected). For deep WM (DWM) ROIs, the number of tests was 42; for superficially located WM (SWM) ROIs, the number of tests was 39; and for GM ROIs of the Multi-Atlas Region Segmentation Utilizing Ensembles template, the number of tests was 120.</p>
                <fig position="float" id="zoi230061f2" fig-type="figure">
                  <label>Figure 2. </label>
                  <caption>
                    <title>Patterns of Changes in the Type III White Matter Parcellation Map–Derived Deep White Matter Regions of Interest When Comparing Intensive Treatment With Standard Treatment </title>
                    <p>A, Changes in white matter lesions. B, Changes in diffusion tensor imaging (DTI) fractional anisotropy. C, Changes in DTI mean diffusivity. The red-yellow color scale indicates effect size; that is, smaller increase over time for intensive treatment compared with standard treatment. The blue-green color scale indicates effect size; that is, larger increase for intensive treatment compared with standard treatment. Changes are significant at <italic>P</italic> &lt; .05, uncorrected. L indicates left; R, right.</p>
                  </caption>
                  <graphic xlink:href="jamanetwopen-e231055-g002" position="float"/>
                </fig>
                <fig position="float" id="zoi230061f3" fig-type="figure">
                  <label>Figure 3. </label>
                  <caption>
                    <title>Patterns of Changes in the Multi-Atlas Region Segmentation Utilizing Ensembles–Derived Gray Matter Regions of Interest When Comparing Cerebral Blood Flow Between Intensive Treatment and Standard Treatment </title>
                    <p>The blue-green color scale indicates effect size; that is, larger increase for intensive treatment compared with standard treatment. Changes are significant at <italic>P</italic> &lt; .05, uncorrected.</p>
                  </caption>
                  <graphic xlink:href="jamanetwopen-e231055-g003" position="float"/>
                </fig>
              </sec>
            </sec>
            <sec id="H1-3-ZOI230061">
              <title>Results</title>
              <sec id="H2-6-ZOI230061">
                <title>Study Participants</title>
                <p>At baseline, 355 participants (mean [SD] age, 67.7 [8.0] years; 200 men [56.3%] and 155 women [43.7%]) received intensive BP treatment and 315 participants (mean [SD] age, 67.0 [8.4] years; 199 men [63.2%] and 116 women [36.8%]) received standard BP treatment (<xref rid="zoi230061t1" ref-type="table">Table</xref>). Information on participants by treatment group is provided in the <xref rid="zoi230061t1" ref-type="table">Table</xref>. Additional baseline characteristics between participants in the MRI substudy and remaining trial participants are shown in eTable 2 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>. The characteristics of the MRI substudy participants who had both baseline and follow-up scans are provided in eTable 3 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>. Group differences are described in eResults 1 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p>
                <table-wrap position="float" id="zoi230061t1">
                  <label>Table. </label>
                  <caption>
                    <title>Characteristics of Participants at Baseline and Follow-up</title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="23.42%" span="1"/>
                    <col width="19.07%" span="1"/>
                    <col width="19.22%" span="1"/>
                    <col width="19.07%" span="1"/>
                    <col width="19.22%" span="1"/>
                    <thead>
                      <tr>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Variable</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Completed baseline scan</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Completed follow-up scan</th>
                      </tr>
                      <tr>
                        <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Intensive treatment (n = 355)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Standard treatment (n = 315)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Intensive treatment (n = 255)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Standard treatment (n = 203)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, mean (SD), y</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">67.7 (8.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">67.0 (8.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">67.9 (7.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">66.6 (7.9)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex, No. (%)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">200 (56.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">199 (63.2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">154 (60.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">133 (65.5)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">155 (43.7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">116 (36.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">101 (39.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">70 (34.5)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Race and ethnicity, No. (%)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Black</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">114 (32.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">104 (33.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">72 (28.2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">66 (32.5)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hispanic<xref rid="zoi230061t1n1" ref-type="table-fn"><sup>a</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (3.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">22 (7.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9 (3.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13 (6.4)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> White</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">222 (62.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">184 (58.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">172 (67.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">120 (59.1)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other<xref rid="zoi230061t1n2" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (1.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (1.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (0.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (2.0)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">BP, mean (SD), mm Hg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Systolic</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">138.2 (17.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">137.8 (15.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">136.0 (16.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">138.4 (16.1)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Diastolic</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">77.3 (10.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">78.5 (12.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">76.6 (10.7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">79.4 (12.2)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Orthostatic hypotension, No. (%)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">26 (7.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">17 (5.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">20 (7.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (7.4)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">eGFR, mL/min/1.73 m<sup>2</sup></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mean (SD)<xref rid="zoi230061t1n3" ref-type="table-fn"><sup>c</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">72.1 (19.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">72.3 (21.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">71.8 (19.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">73.7 (20.9)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &lt;60, No. (%)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">95 (26.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">91 (28.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">67 (26.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">56 (27.6)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Intracranial volume, mean (SD), mm<sup>3</sup></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1373.9 (149.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1394.1 (145.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1387.3 (141.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1398.1 (146.3)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">WML volume, mean (SD), mm<sup>3</sup></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3068.2 (5475.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2639.9 (4454.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3712.6 (6585.1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3898.0 (6299.7)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">DWM DTI-FA, mean (SD)<xref rid="zoi230061t1n4" ref-type="table-fn"><sup>d</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.4130 (0.036)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.4156 (0.028)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.4104 (0.036)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.4094 (0.033)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">SWM DTI-FA, mean (SD)<xref rid="zoi230061t1n4" ref-type="table-fn"><sup>d</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.3387 (0.033)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.3408 (0.028)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.3376 (0.036)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.3368 (0.032)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">DWM DTI-MD, mean (SD)<xref rid="zoi230061t1n4" ref-type="table-fn"><sup>d</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.8480 (0.310)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.8318 (0.051)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.8524 (0.061)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.8502 (0.057)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">SWM DTI-MD, mean (SD)<xref rid="zoi230061t1n4" ref-type="table-fn"><sup>d</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.8016 (0.190)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.7947 (0.045)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.8054 (0.047)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.8020 (0.045)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">GM CBF, mean (SD), mL/100 mg/min</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">35.9 (11.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">35.3 (10.4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">40.5 (15.2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">38.9 (14.1)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: BP, blood pressure; CBF, cerebral blood flow; DTI, diffusion tensor imaging; DWM, deep white matter; eGFR, estimated glomerular filtration rate; FA, fractional anisotropy; GM, gray matter; MD, mean diffusivity; SWM, superficially located white matter; WML, white matter lesion.</p>
                    <fn id="zoi230061t1n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Encompasses a self-report of being of Spanish, Hispanic, or Latino origin, independent of any other race and ethnicity designation.</p>
                    </fn>
                    <fn id="zoi230061t1n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Includes Asian, American Indian or Alaskan Native, Native Hawaiian or Pacific Islander, or other races.</p>
                    </fn>
                    <fn id="zoi230061t1n3">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>Based on Modification of Diet in Renal Disease Study equation.</p>
                    </fn>
                    <fn id="zoi230061t1n4">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>Scalar values.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="H2-7-ZOI230061">
                <title>White Matter Lesions</title>
                <p>Overall, intensive treatment was associated with smaller mean increases in WML volume compared with standard treatment (644.5 mm<sup>3</sup> vs 1258.1 mm<sup>3</sup>; <xref rid="zoi230061t1" ref-type="table">Table</xref>). Specifically, the smaller increases were observed in the DWM regions, such as the left anterior corona radiata (intensive treatment, 30.3 mm<sup>3</sup> [95% CI, 16.0-44.5 mm<sup>3</sup>]; standard treatment, 80.5 mm<sup>3</sup> [95% CI, 53.8-107.2 mm<sup>3</sup>]; <italic>P</italic> = .003), left tapetum (intensive treatment, 11.8 mm<sup>3</sup> [95% CI, 4.4-19.2 mm<sup>3</sup>]; standard treatment, 27.2 mm<sup>3</sup> [95% CI, 19.4-35.0 mm<sup>3</sup>]; <italic>P</italic> = .046), left superior fronto-occipital fasciculus (intensive treatment, 3.2 mm<sup>3</sup> [95% CI, 0.7-5.8 mm<sup>3</sup>]; standard treatment, 9.4 mm<sup>3</sup> [95% CI, 5.5-13.4 mm<sup>3</sup>]; <italic>P</italic> = .046), left posterior corona radiata (intensive treatment, 26.0 mm<sup>3</sup> [95% CI, 12.9-39.1 mm<sup>3</sup>]; standard treatment, 52.3 mm<sup>3</sup> [95% CI, 34.8-69.8 mm<sup>3</sup>]; <italic>P</italic> = .046), left splenium of the corpus callosum (intensive treatment, 45.4 mm<sup>3</sup> [95% CI, 25.1-65.7 mm<sup>3</sup>]; standard treatment, 83.0 mm<sup>3</sup> [95% CI, 58.7-107.2 mm<sup>3</sup>]; <italic>P</italic> = .046), left posterior thalamic radiation (intensive treatment, 53.0 mm<sup>3</sup> [95% CI, 29.8-76.2 mm<sup>3</sup>]; standard treatment, 106.9 mm<sup>3</sup> [95% CI, 73.4-140.3 mm<sup>3</sup>]; <italic>P</italic> = .046), and right posterior thalamic radiation (intensive treatment, 49.5 mm<sup>3</sup> [95% CI, 24.3-74.7 mm<sup>3</sup>]; standard treatment, 102.6 mm<sup>3</sup> [95% CI, 71.0-134.2 mm<sup>3</sup>]; <italic>P</italic> = .047) (<xref rid="zoi230061f2" ref-type="fig">Figure 2</xref>A). Smaller increases in WML volume were associated with intensive treatment in the right body of the corpus callosum, right splenium, right anterior corona radiata, right posterior corona radiata, left anterior limb of the internal capsule, and right tapetum (<xref rid="zoi230061f2" ref-type="fig">Figure 2</xref>A). For all WM ROIs, the effect sizes and changes per group are reported in eTable 4 and eTable 5 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>. Changes in SWM ROIs for WMLs are described in eResults 2 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p>
              </sec>
              <sec id="H2-8-ZOI230061">
                <title>DTI: Fractional Anisotropy and Mean Diffusivity</title>
                <p>Overall, we noted that the FA was associated with a slower decrease over time with intensive treatment (mean change, −0.0026 for DWM ROIs and −0.0011 for SWM ROIs) compared with standard treatment (mean change, −0.0062 for DWM ROIs and −0.0040 for SWM ROIs), as shown in the <xref rid="zoi230061t1" ref-type="table">Table</xref>. Deep WM regions, such as the left posterior thalamic radiation (intensive treatment, –0.0003 [95% CI, –0.0052 to 0.0047]; standard treatment, –0.0049 [–0.0105 to 0.0005]; uncorrected <italic>P</italic> = .01), left superior fronto-occipital fasciculus (intensive treatment, 0.0108 [95% CI, 0.0043-0.0173]; standard treatment 0.0002 [95% CI, –0.0055 to 0.0059]; uncorrected <italic>P</italic> = .02), left anterior limb of the internal capsule (intensive treatment, 0.0061 [95% CI, 0.0013-0.0109]; standard treatment, –0.0005 [95% CI, –0.0053 to 0.0043]; uncorrected <italic>P</italic> = .03), left tapetum (intensive treatment, 0.0025 [95% CI, –0.0045 to 0.0096]; standard treatment, –0.0041 [95% CI, –0.0126 to 0.0045]; uncorrected <italic>P</italic> = .04), left sagittal stratum (intensive treatment, –0.0046 [95% CI, –0.0089 to –0.0004]; standard treatment, –0.0098 [95% CI, –0.0146 to –0.005]; uncorrected <italic>P</italic> = .047), and right anterior corona radiata (intensive treatment, –0.0013 [95% CI, –0.0044 to 0.0017]; standard treatment, –0.0048 [95% CI, –0.0079 to –0.0017]; uncorrected <italic>P</italic> = .047), experienced slower decreases in FA associated with intensive treatment (<xref rid="zoi230061f2" ref-type="fig">Figure 2</xref>B).</p>
                <p>Intensive treatment was associated with an overall smaller mean increase in MD compared with standard treatment (0.0044 vs 0.0184 for DWM ROIs and 0.0038 vs 0.0073 for SWM ROIs [<xref rid="zoi230061t1" ref-type="table">Table</xref>]). Specifically, smaller increases were observed in the left superior fronto-occipital fasciculus (intensive treatment, 0.0158 [95% CI, 0.0042-0.0275]; standard treatment, 0.0317 [95% CI, 0.0219-0.0414]; uncorrected <italic>P</italic> = .03), left posterior thalamic radiation (intensive treatment, 0.0154 [95% CI, 0.0086-0.0221]; standard treatment, 0.0226 [95% CI, 0.0151-0.0301]; uncorrected <italic>P</italic> = .04), and left tapetum (intensive treatment, 0.0335 [95% CI, 0.0179-0.0491]; standard treatment, 0.0533 [95% CI, 0.0354-0.0711]; uncorrected <italic>P</italic> = .047) (<xref rid="zoi230061f2" ref-type="fig">Figure 2</xref>C). eTables 6 to 9 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref> report the effect size, mean change per ROI, mean MD at baseline, and mean MD at follow-up per treatment group for all the WM ROIs. Changes in SWM ROIs for FA and MD are described in eResults 2 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p>
              </sec>
              <sec id="H2-9-ZOI230061">
                <title>Cerebral Blood Flow</title>
                <p>Overall, there was a larger increase in mean CBF associated with intensive treatment compared with standard treatment (4.6 mL/100 mg/min vs 3.7 mL/100 mg/min; <xref rid="zoi230061t1" ref-type="table">Table</xref>). Specifically, larger increases in CBF with intensive treatment were noted in in the right middle occipital gyrus (intensive treatment, 8.8 mL/100 mg/min [95% CI, 5.5-12.2 mL/100 mg/min]; standard treatment, 1.1 mL/100 mg/min [95% CI, –3.7 to 6.0 mL/100 mg/min]; uncorrected <italic>P</italic> = .004), left cuneus (intensive treatment, 6.2 mL/100 mg/min [95% CI, 3.8-8.6 mL/100 mg/min]; standard treatment, 3.1 mL/100 mg/min [95% CI, 0.4-5.7 mL/100 mg/min]; uncorrected <italic>P</italic> = .02), left superior occipital gyrus (intensive treatment, 6.5 mL/100 mg/min [95% CI, 3.7-9.4 mL/100 mg/min]; standard treatment, 0.7 mL/100 mg/min [95% CI, –4.0 to 5.4 mL/100 mg/min]; uncorrected <italic>P</italic> = .02), right inferior occipital gyrus (intensive treatment, 7.1 mL/100 mg/min [95% CI, 4.1-10.1 mL/100 mg/min]; standard treatment, 2.4 mL/100 mg/min [95% CI, –0.9 to 5.8 mL/100 mg/min]; uncorrected <italic>P</italic> = .03), right cuneus (intensive treatment, 6.0 mL/100 mg/min [95% CI, 3.7-8.4 mL/100 mg/min]; standard treatment, 2.9 mL/100 mg/min [95% CI, 0.0-5.7 mL/100 mg/min]; uncorrected <italic>P</italic> = .03), left inferior occipital gyrus (intensive treatment, 8.0 mL/100 mg/min [95% CI, 4.9-11.2 mL/100 mg/min]; standard treatment, 2.6 mL/100 mg/min [95% CI, –1.5 to 6.8 mL/100 mg/min]; uncorrected <italic>P</italic> = .03), right occipital pole (intensive treatment, 9.5 mL/100 mg/min [95% CI, 5.4-13.6 mL/100 mg/min]; standard treatment, 2.4 mL/100 mg/min [95% CI, –2.9 to 7.7 mL/100 mg/min]; uncorrected <italic>P</italic> = .03), right superior occipital gyrus (intensive treatment, 5.5 mL/100 mg/min [95% CI, 2.6-8.4 mL/100 mg/min]; standard treatment, 0.1 mL/100 mg/min [95% CI, –4.4 to 4.6 mL/100 mg/min]; uncorrected <italic>P</italic> = .04), right middle frontal gyrus (intensive treatment, 1.3 mL/100 mg/min [95% CI, –1.0 to 3.5 mL/100 mg/min]; standard treatment, –1.6 mL/100 mg/min [95% CI, –3.9 to 0.8 mL/100 mg/min]; uncorrected <italic>P</italic> = .04), left superior parietal lobule (intensive treatment, 1.1 mL/100 mg/min [95% CI, –0.9 to 3.0 mL/100 mg/min]; standard treatment, –2.2 mL/100 mg/min [95% CI, –5.2 to 0.8 mL/100 mg/min]; uncorrected <italic>P</italic> = .045), left precentral gyrus (intensive treatment, 1.8 mL/100 mg/min [95% CI, –0.3 to 4.0 mL/100 mg/min]; standard treatment, –0.9 mL/100 mg/min [95% CI, –3.4 to 1.7 mL/100 mg/min]; uncorrected <italic>P</italic> = .046), and right supramarginal gyrus (intensive treatment, 5.9 mL/100 mg/min [95% CI, 3.1-8.6 mL/100 mg/min]; standard treatment, 2.9 mL/100 mg/min [95% CI, –0.2 to 5.9 mL/100 mg/min]; uncorrected <italic>P</italic> = .049) (<xref rid="zoi230061f3" ref-type="fig">Figure 3</xref>). eTable 10 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref> reports the effect size, mean change per group, mean CBF at baseline, and mean CBF at follow-up for all GM ROIs.</p>
              </sec>
              <sec id="H2-10-ZOI230061">
                <title>Sensitivity Analysis</title>
                <p>We performed multiple imputation (eMethods 2 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>) to account for bias due to missing follow-up data (eTable 11 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>). The results showed an association between intensive treatment and reduced progression of WMLs in the left anterior corona radiata, left tapetum, left superior fronto-occipital fasciculus, left posterior corona radiata, left splenium of the corpus callosum, both sides of the posterior thalamic radiation, right body of the corpus callosum, right splenium, right anterior corona radiata, right posterior corona radiata, left anterior limb of the internal capsule, and right tapetum (eTable 12 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>).</p>
              </sec>
            </sec>
            <sec id="H1-4-ZOI230061">
              <title>Discussion</title>
              <p>Intensive SBP treatment was associated with reduced progression of WMLs in the anterior and posterior corona radiata, tapetum, superior fronto-occipital fasciculus, and the corpus callosum in this post hoc substudy of the SPRINT MIND clinical trial. Further analyses indicated a slower decrease in FA, a slower increase in MD, and an improvement in CBF associated with intensive treatment. Overall, our results were consistent with prior findings in other studies. Reduction of WML progression due to BP treatment has been reported previously in the INFINITY (Intensive Versus Standard Ambulatory Blood Pressure Lowering to Prevent Functional Decline In the Elderly) trial,<sup><xref rid="zoi230061r44" ref-type="bibr">44</xref></sup> PRESERVE (How Intensively Should We Treat Blood Pressure in Established Cerebral Small Vessel Disease) trial,<sup><xref rid="zoi230061r45" ref-type="bibr">45</xref></sup> PROGRESS (Perindopril Protection Against Recurrent Stroke Study),<sup><xref rid="zoi230061r46" ref-type="bibr">46</xref></sup> ACCORD-MIND (Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes) study,<sup><xref rid="zoi230061r47" ref-type="bibr">47</xref></sup> and others.<sup><xref rid="zoi230061r48" ref-type="bibr">48</xref>,<xref rid="zoi230061r49" ref-type="bibr">49</xref></sup> These studies treated WML as a scored lesion load across the whole brain,<sup><xref rid="zoi230061r45" ref-type="bibr">45</xref>,<xref rid="zoi230061r48" ref-type="bibr">48</xref>,<xref rid="zoi230061r49" ref-type="bibr">49</xref></sup> total volume,<sup><xref rid="zoi230061r44" ref-type="bibr">44</xref>,<xref rid="zoi230061r47" ref-type="bibr">47</xref></sup> or both.<sup><xref rid="zoi230061r46" ref-type="bibr">46</xref></sup> To our knowledge, this is the first study with a large-scale longitudinal cohort examining the regional associations of BP treatment with WMLs, DTI measures, and CBF using data from a randomized double-blind clinical trial targeting hypertension treatment.</p>
              <sec id="H2-11-ZOI230061">
                <title>WML Volume Changes With Strict BP Control</title>
                <p>This study suggests that intensive BP treatment was associated with a slowing of WML increase in the DWM of the corona radiata and thalamic radiations, along with some of the commissural fibers in the corpus callosum. Our analysis points to the beneficial associations of intensive BP treatment (specifically, injury patterns related to dementia). A previous cross-sectional study<sup><xref rid="zoi230061r50" ref-type="bibr">50</xref></sup> reported decreased WML volume in the corpus callosum and anterior or posterior corona radiata among patients with vascular dementia and patients with mild cognitive impairment of vascular origins. Our study suggests that intensive BP treatment is associated with reduced WM damage and the prevention of WMLs in these tracts, which in turn could preserve myelin structures along these tracts and ultimately slow the progression of injury patterns associated with dementia.</p>
                <p>Superficially located WM lesion progression differences were found between the 2 groups (eFigure, A, and eTable 2 in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>). The SWM lesions were neighboring the DWM regions and, similar to the DWM findings, had a pattern of reduced WML progression over time associated with intensive treatment compared with standard treatment (eFigure, A, in <xref rid="note-ZOI230061-1-s" ref-type="supplementary-material">Supplement 2</xref>). Superficially located WM has less myelination and tends to be more vulnerable to pathologic damage.<sup><xref rid="zoi230061r51" ref-type="bibr">51</xref>,<xref rid="zoi230061r52" ref-type="bibr">52</xref></sup></p>
              </sec>
              <sec id="H2-12-ZOI230061">
                <title>DTI Changes With Strict BP Control</title>
                <p>Fractional anisotropy is indicative of the direction of the diffusion of water molecules, while MD describes the rotationally invariant magnitude of the diffusion. Higher FA values are typically observed in heavily myelinated WM tracts,<sup><xref rid="zoi230061r53" ref-type="bibr">53</xref></sup> and lower values have been associated with pathologic findings. The Multi-Ethnic Study of Atherosclerosis, using a comparable DTI processing pipeline, indicated that global FA decreases by approximately 0.26 per 5 years in the population in the eighth decade of life.<sup><xref rid="zoi230061r33" ref-type="bibr">33</xref></sup> However, reports on regional DTI measures in the population are scarce, and reference data are therefore less available, to our knowledge.</p>
                <p>Changes in FA and, to a lesser extent, MD, generally aligned with WML findings, with strict BP control associated with smaller decreases in FA and smaller increases in MD over time with intensive treatment. The PRESERVE study<sup><xref rid="zoi230061r45" ref-type="bibr">45</xref></sup> did not find any associations between BP treatment and DTI measures. As reported in a previous substudy,<sup><xref rid="zoi230061r27" ref-type="bibr">27</xref></sup> we found no significant differences in mean FA for any parts of the corpus callosum or cingulum. This finding may be due to the greater interindividual variability of FA in the corpus callosum,<sup><xref rid="zoi230061r54" ref-type="bibr">54</xref></sup> which makes it more difficult to properly assess the structure accurately from a registration perspective despite good reproducibility of results longitudinally. However, it cannot be ruled out that there may be an underlying difference in the WM microstructure (due to differing pathologic damage in the commissural fibers compared with nearby projection fibers) that was associated with the difference in FA, which is worth future investigation. The same study<sup><xref rid="zoi230061r54" ref-type="bibr">54</xref></sup> also found similar higher reproducibility with lower reliability in MD to an even greater extent compared with FA, which may explain the lack of significant differences found in MD between the 2 treatment groups.</p>
              </sec>
              <sec id="H2-13-ZOI230061">
                <title>CBF Changes With Strict BP Control</title>
                <p>When gross measures such as global GM CBF were assessed,<sup><xref rid="zoi230061r28" ref-type="bibr">28</xref></sup> no significant differences were found between the 2 treatment groups. Our regional analysis, on the other hand, could have been more sensitive, as individual regions have inconsistent directions associated with intensive BP control (increase vs decrease), and therefore had an attenuated overall outcome. Nonetheless, significant unadjusted <italic>P</italic> values were associated with intensive treatment in all instances. Our study showed that intensive BP control was associated with increased blood perfusion, especially in the occipital lobe. Previous cross-sectional studies<sup><xref rid="zoi230061r55" ref-type="bibr">55</xref></sup> showed decreased occipital perfusion for participants with hypertension. SPRINT had a lower BP goal (&lt;120 mm Hg) than previous observational longitudinal studies of BP control.<sup><xref rid="zoi230061r48" ref-type="bibr">48</xref>,<xref rid="zoi230061r56" ref-type="bibr">56</xref>,<xref rid="zoi230061r57" ref-type="bibr">57</xref></sup> This finding suggests that even with more aggressive BP goals, cerebrovascular autoregulatory mechanisms will compensate for the decreased systemic BP, preventing hypoperfusion and leading to improvements in regional CBF. These changes likely take place at a capillary level.<sup><xref rid="zoi230061r58" ref-type="bibr">58</xref></sup> In our study, CBF improvement was mainly localized to posterior cerebral circulation. Although the cause of this topographical preference is unclear, one hypothesis is that posterior and anterior cerebral circulation may have different regulatory mechanisms for blood flow that make the posterior circulation more vulnerable to vascular dysfunction, which is improved with strict BP control back to a nonhypertensive state.<sup><xref rid="zoi230061r59" ref-type="bibr">59</xref>,<xref rid="zoi230061r60" ref-type="bibr">60</xref></sup> Studies investigating this hypothesis have produced mixed findings on whether there is diminished autoregulatory capacity in the posterior circulation<sup><xref rid="zoi230061r61" ref-type="bibr">61</xref>,<xref rid="zoi230061r62" ref-type="bibr">62</xref>,<xref rid="zoi230061r63" ref-type="bibr">63</xref></sup> or not.<sup><xref rid="zoi230061r64" ref-type="bibr">64</xref>,<xref rid="zoi230061r65" ref-type="bibr">65</xref></sup> Previous studies have demonstrated relatively confined regions of decreased cerebral blood flow as a result of hypertension. Among patients with treated hypertension, there are still areas of hypoperfusion in the left parietal and right frontorolandic regions compared with controls<sup><xref rid="zoi230061r66" ref-type="bibr">66</xref></sup> (as opposed to global cerebral hypoperfusion in patients with untreated hypertension).</p>
                <p>Another study showed that participants with hypertension showed reduced temporal and occipital perfusion compared with those without hypertension, regardless of antihypertensive treatment status.<sup><xref rid="zoi230061r55" ref-type="bibr">55</xref></sup> Although it is difficult to hypothesize the exact biological cause of the specific regional differences due to varying study designs, we believe that this finding nevertheless demonstrates that regional perfusion differences may emerge with hypertension or hypertension control that may not be reflected in global perfusion comparisons after being averaged out. In the previous analysis of the secondary outcomes, there was a small increase in GM CBF associated with intensive treatment compared with standard treatment that did not reach statistical significance, likely owing in part to these regional differences.</p>
                <p>A limitation is that these studies have been focused on compensatory mechanisms to more abrupt changes as opposed to long-term differences over the course of years. Nevertheless, the findings in this substudy of potential posterior-anterior circulation differences may merit further investigation.</p>
              </sec>
              <sec id="H2-14-ZOI230061">
                <title>Limitations</title>
                <p>There are some limitations in this study. First is the 4-year duration between the start of intervention and follow-up. Second is the fact that fewer participants completed follow-up MRI scans, partially due to early termination of the trial. Third is that the reported DTI and CBF measures did not show significance after multiple comparisons (possibly due to a higher noise-to-signal ratio in DTI and CBF compared with fluid-attenuated inversion recovery), and their interpretations should be considered exploratory. Increasing the sample size in future clinical trials would help in reaching statistical significance after correction for multiple comparisons for regional analyses in those modalities.</p>
              </sec>
            </sec>
            <sec id="H1-5-ZOI230061">
              <title>Conclusions</title>
              <p>In this post hoc secondary analysis of a randomized clinical trial of SBP control, intensive treatment, compared with standard treatment, of hypertension was associated with decreased progression of WMLs, specifically in the left anterior corona radiata, left tapetum, left superior fronto-occipital fasciculus, posterior thalamic radiations, left posterior corona radiata, and left splenium of the corpus callosum. Corresponding changes in mean FA (in overlapping regions, mainly the left posterior thalamic radiation, left superior fronto-occipital fasciculus, left anterior limb of internal capsule, left tapetum, and right anterior corona radiata) and MD (mainly in the left superior fronto-occipital fasciculus, left posterior thalamic radiation, and left tapetum) had a marginal association among other regions, suggesting the vulnerability of those regions to hypertension. Intensive SBP control was also associated with improved posterior cerebral perfusion. Our findings support the hypothesis that intensive BP treatment has beneficial associations with small vessel disease biomarkers. Specific areas show greater benefit, representing sensitive regions to track in future trials evaluating small vessel disease.</p>
            </sec>
          </body>
          <back>
            <ref-list id="REF-ZOI230061">
              <title>References</title>
              <ref id="zoi230061r1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Chobanian</surname><given-names>AV</given-names></string-name>, <string-name><surname>Bakris</surname><given-names>GL</given-names></string-name>, <string-name><surname>Black</surname><given-names>HR</given-names></string-name>, <etal/>; <collab>Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</collab>; <collab>National Heart, Lung, and Blood Institute</collab>; <collab>National High Blood Pressure Education Program Coordinating Committee</collab></person-group>. <article-title>Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</article-title>. <source>Hypertension</source>. <year>2003</year>;<volume>42</volume>(<issue>6</issue>):<fpage>1206</fpage>-<lpage>1252</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.HYP.0000107251.49515.c2</pub-id><?supplied-pmid 14656957?><pub-id pub-id-type="pmid">14656957</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Virani</surname><given-names>SS</given-names></string-name>, <string-name><surname>Alonso</surname><given-names>A</given-names></string-name>, <string-name><surname>Aparicio</surname><given-names>HJ</given-names></string-name>, <etal/>; <collab>American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee</collab></person-group>. <article-title>Heart disease and stroke statistics—2021 update: a report from the American Heart Association</article-title>. <source>Circulation</source>. <year>2021</year>;<volume>143</volume>(<issue>8</issue>):<fpage>e254</fpage>-<lpage>e743</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIR.0000000000000950</pub-id><?supplied-pmid 33501848?><pub-id pub-id-type="pmid">33501848</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Chobanian</surname><given-names>AV</given-names></string-name>, <string-name><surname>Bakris</surname><given-names>GL</given-names></string-name>, <string-name><surname>Black</surname><given-names>HR</given-names></string-name>, <etal/>; <collab>National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</collab>; <collab>National High Blood Pressure Education Program Coordinating Committee</collab></person-group>. <article-title>The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report</article-title>. <source>JAMA</source>. <year>2003</year>;<volume>289</volume>(<issue>19</issue>):<fpage>2560</fpage>-<lpage>2572</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.289.19.2560</pub-id><?supplied-pmid 12748199?><pub-id pub-id-type="pmid">12748199</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Habes</surname><given-names>M</given-names></string-name>, <string-name><surname>Erus</surname><given-names>G</given-names></string-name>, <string-name><surname>Toledo</surname><given-names>JB</given-names></string-name>, <etal/></person-group>. <article-title>White matter hyperintensities and imaging patterns of brain ageing in the general population</article-title>. <source>Brain</source>. <year>2016</year>;<volume>139</volume>(<issue>Pt 4</issue>):<fpage>1164</fpage>-<lpage>1179</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/aww008</pub-id><?supplied-pmid 26912649?><pub-id pub-id-type="pmid">26912649</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Habes</surname><given-names>M</given-names></string-name>, <string-name><surname>Erus</surname><given-names>G</given-names></string-name>, <string-name><surname>Toledo</surname><given-names>JB</given-names></string-name>, <etal/></person-group>. <article-title>Regional tract-specific white matter hyperintensities are associated with patterns to aging-related brain atrophy via vascular risk factors, but also independently</article-title>. <source>Alzheimers Dement (Amst)</source>. <year>2018</year>;<volume>10</volume>:<fpage>278</fpage>-<lpage>284</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.dadm.2018.02.002</pub-id><?supplied-pmid 29644327?><pub-id pub-id-type="pmid">29644327</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Wardlaw</surname><given-names>JM</given-names></string-name>, <string-name><surname>Valdés Hernández</surname><given-names>MC</given-names></string-name>, <string-name><surname>Muñoz-Maniega</surname><given-names>S</given-names></string-name></person-group>. <article-title>What are white matter hyperintensities made of? relevance to vascular cognitive impairment</article-title>. <source>J Am Heart Assoc</source>. <year>2015</year>;<volume>4</volume>(<issue>6</issue>):<elocation-id>001140</elocation-id>. doi:<pub-id pub-id-type="doi">10.1161/JAHA.114.001140</pub-id><?supplied-pmid 26104658?><pub-id pub-id-type="pmid">26104658</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Gons</surname><given-names>RA</given-names></string-name>, <string-name><surname>de Laat</surname><given-names>KF</given-names></string-name>, <string-name><surname>van Norden</surname><given-names>AG</given-names></string-name>, <etal/></person-group>. <article-title>Hypertension and cerebral diffusion tensor imaging in small vessel disease</article-title>. <source>Stroke</source>. <year>2010</year>;<volume>41</volume>(<issue>12</issue>):<fpage>2801</fpage>-<lpage>2806</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.110.597237</pub-id><?supplied-pmid 21030696?><pub-id pub-id-type="pmid">21030696</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>van Veluw</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Scherlek</surname><given-names>AA</given-names></string-name>, <string-name><surname>Freeze</surname><given-names>WM</given-names></string-name>, <etal/></person-group>. <article-title>Different microvascular alterations underlie microbleeds and microinfarcts</article-title>. <source>Ann Neurol</source>. <year>2019</year>;<volume>86</volume>(<issue>2</issue>):<fpage>279</fpage>-<lpage>292</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.25512</pub-id><?supplied-pmid 31152566?><pub-id pub-id-type="pmid">31152566</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sabisz</surname><given-names>A</given-names></string-name>, <string-name><surname>Naumczyk</surname><given-names>P</given-names></string-name>, <string-name><surname>Marcinkowska</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Aging and hypertension—independent or intertwined white matter impairing factors? insights from the quantitative diffusion tensor imaging</article-title>. <source>Front Aging Neurosci</source>. <year>2019</year>;<volume>11</volume>:<fpage>35</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2019.00035</pub-id><?supplied-pmid 30837864?><pub-id pub-id-type="pmid">30837864</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Palesi</surname><given-names>F</given-names></string-name>, <string-name><surname>De Rinaldis</surname><given-names>A</given-names></string-name>, <string-name><surname>Vitali</surname><given-names>P</given-names></string-name>, <etal/></person-group>. <article-title>Specific patterns of white matter alterations help distinguishing Alzheimer’s and vascular dementia</article-title>. <source>Front Neurosci</source>. <year>2018</year>;<volume>12</volume>:<fpage>274</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnins.2018.00274</pub-id><?supplied-pmid 29922120?><pub-id pub-id-type="pmid">29922120</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Habes</surname><given-names>M</given-names></string-name>, <string-name><surname>Pomponio</surname><given-names>R</given-names></string-name>, <string-name><surname>Shou</surname><given-names>H</given-names></string-name>, <etal/>; <collab>iSTAGING consortium, the Preclinical AD consortium, the ADNI, and the CARDIA studies</collab></person-group>. <article-title>The brain chart of aging: machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans</article-title>. <source>Alzheimers Dement</source>. <year>2021</year>;<volume>17</volume>(<issue>1</issue>):<fpage>89</fpage>-<lpage>102</lpage>. doi:<pub-id pub-id-type="doi">10.1002/alz.12178</pub-id><?supplied-pmid 32920988?><pub-id pub-id-type="pmid">32920988</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Habes</surname><given-names>M</given-names></string-name>, <string-name><surname>Sotiras</surname><given-names>A</given-names></string-name>, <string-name><surname>Erus</surname><given-names>G</given-names></string-name>, <etal/></person-group>. <article-title>White matter lesions: spatial heterogeneity, links to risk factors, cognition, genetics, and atrophy</article-title>. <source>Neurology</source>. <year>2018</year>;<volume>91</volume>(<issue>10</issue>):<fpage>e964</fpage>-<lpage>e975</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000006116</pub-id><?supplied-pmid 30076276?><pub-id pub-id-type="pmid">30076276</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sugihara</surname><given-names>S</given-names></string-name>, <string-name><surname>Kinoshita</surname><given-names>T</given-names></string-name>, <string-name><surname>Matsusue</surname><given-names>E</given-names></string-name>, <string-name><surname>Fujii</surname><given-names>S</given-names></string-name>, <string-name><surname>Ogawa</surname><given-names>T</given-names></string-name></person-group>. <article-title>Usefulness of diffusion tensor imaging of white matter in Alzheimer disease and vascular dementia</article-title>. <source>Acta Radiol</source>. <year>2004</year>;<volume>45</volume>(<issue>6</issue>):<fpage>658</fpage>-<lpage>663</lpage>. doi:<pub-id pub-id-type="doi">10.1080/02841850410008388</pub-id><?supplied-pmid 15587425?><pub-id pub-id-type="pmid">15587425</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>McAleese</surname><given-names>KE</given-names></string-name>, <string-name><surname>Miah</surname><given-names>M</given-names></string-name>, <string-name><surname>Graham</surname><given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology</article-title>. <source>Acta Neuropathol</source>. <year>2021</year>;<volume>142</volume>(<issue>6</issue>):<fpage>937</fpage>-<lpage>950</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00401-021-02376-2</pub-id><?supplied-pmid 34608542?><pub-id pub-id-type="pmid">34608542</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>McAleese</surname><given-names>KE</given-names></string-name>, <string-name><surname>Walker</surname><given-names>L</given-names></string-name>, <string-name><surname>Graham</surname><given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease</article-title>. <source>Acta Neuropathol</source>. <year>2017</year>;<volume>134</volume>(<issue>3</issue>):<fpage>459</fpage>-<lpage>473</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00401-017-1738-2</pub-id><?supplied-pmid 28638989?><pub-id pub-id-type="pmid">28638989</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Kantarci</surname><given-names>K</given-names></string-name>, <string-name><surname>Murray</surname><given-names>ME</given-names></string-name>, <string-name><surname>Schwarz</surname><given-names>CG</given-names></string-name>, <etal/></person-group>. <article-title>White-matter integrity on DTI and the pathologic staging of Alzheimer’s disease</article-title>. <source>Neurobiol Aging</source>. <year>2017</year>;<volume>56</volume>:<fpage>172</fpage>-<lpage>179</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.04.024</pub-id><?supplied-pmid 28552181?><pub-id pub-id-type="pmid">28552181</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lee</surname><given-names>DY</given-names></string-name>, <string-name><surname>Fletcher</surname><given-names>E</given-names></string-name>, <string-name><surname>Martinez</surname><given-names>O</given-names></string-name>, <etal/></person-group>. <article-title>Vascular and degenerative processes differentially affect regional interhemispheric connections in normal aging, mild cognitive impairment, and Alzheimer disease</article-title>. <source>Stroke</source>. <year>2010</year>;<volume>41</volume>(<issue>8</issue>):<fpage>1791</fpage>-<lpage>1797</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.110.582163</pub-id><?supplied-pmid 20595668?><pub-id pub-id-type="pmid">20595668</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r18">
                <label>18</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Curran</surname><given-names>KM</given-names></string-name>, <string-name><surname>Emsell</surname><given-names>L</given-names></string-name>, <string-name><surname>Leemans</surname><given-names>A</given-names></string-name></person-group>. <source>Quantitative DTI Measures: Diffusion Tensor Imaging</source>. <publisher-name>Springer</publisher-name>; <year>2016</year>:<fpage>65</fpage>-<lpage>87</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-1-4939-3118-7_5</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Detre</surname><given-names>JA</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>W</given-names></string-name>, <string-name><surname>Roberts</surname><given-names>DA</given-names></string-name>, <etal/></person-group>. <article-title>Tissue specific perfusion imaging using arterial spin labeling</article-title>. <source>NMR Biomed</source>. <year>1994</year>;<volume>7</volume>(<issue>1-2</issue>):<fpage>75</fpage>-<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1002/nbm.1940070112</pub-id><?supplied-pmid 8068529?><pub-id pub-id-type="pmid">8068529</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Pollock</surname><given-names>JM</given-names></string-name>, <string-name><surname>Tan</surname><given-names>H</given-names></string-name>, <string-name><surname>Kraft</surname><given-names>RA</given-names></string-name>, <string-name><surname>Whitlow</surname><given-names>CT</given-names></string-name>, <string-name><surname>Burdette</surname><given-names>JH</given-names></string-name>, <string-name><surname>Maldjian</surname><given-names>JA</given-names></string-name></person-group>. <article-title>Arterial spin-labeled MR perfusion imaging: clinical applications</article-title>. <source>Magn Reson Imaging Clin N Am</source>. <year>2009</year>;<volume>17</volume>(<issue>2</issue>):<fpage>315</fpage>-<lpage>338</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mric.2009.01.008</pub-id><?supplied-pmid 19406361?><pub-id pub-id-type="pmid">19406361</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Croall</surname><given-names>ID</given-names></string-name>, <string-name><surname>Tozer</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Moynihan</surname><given-names>B</given-names></string-name>, <etal/>; <collab>PRESERVE Study Team</collab></person-group>. <article-title>Effect of standard vs intensive blood pressure control on cerebral blood flow in small vessel disease: the PRESERVE randomized clinical trial</article-title>. <source>JAMA Neurol</source>. <year>2018</year>;<volume>75</volume>(<issue>6</issue>):<fpage>720</fpage>-<lpage>727</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamaneurol.2017.5153</pub-id><?supplied-pmid 29507944?><pub-id pub-id-type="pmid">29507944</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Foster-Dingley</surname><given-names>JC</given-names></string-name>, <string-name><surname>Moonen</surname><given-names>JE</given-names></string-name>, <string-name><surname>de Craen</surname><given-names>AJ</given-names></string-name>, <string-name><surname>de Ruijter</surname><given-names>W</given-names></string-name>, <string-name><surname>van der Mast</surname><given-names>RC</given-names></string-name>, <string-name><surname>van der Grond</surname><given-names>J</given-names></string-name></person-group>. <article-title>Blood pressure is not associated with cerebral blood flow in older persons</article-title>. <source>Hypertension</source>. <year>2015</year>;<volume>66</volume>(<issue>5</issue>):<fpage>954</fpage>-<lpage>960</lpage>. doi:<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.115.05799</pub-id><?supplied-pmid 26351027?><pub-id pub-id-type="pmid">26351027</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Tryambake</surname><given-names>D</given-names></string-name>, <string-name><surname>He</surname><given-names>J</given-names></string-name>, <string-name><surname>Firbank</surname><given-names>MJ</given-names></string-name>, <string-name><surname>O’Brien</surname><given-names>JT</given-names></string-name>, <string-name><surname>Blamire</surname><given-names>AM</given-names></string-name>, <string-name><surname>Ford</surname><given-names>GA</given-names></string-name></person-group>. <article-title>Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension</article-title>. <source>Hypertension</source>. <year>2013</year>;<volume>61</volume>(<issue>6</issue>):<fpage>1309</fpage>-<lpage>1315</lpage>. doi:<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.112.200972</pub-id><?supplied-pmid 23529166?><pub-id pub-id-type="pmid">23529166</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Wright</surname><given-names>JT</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Williamson</surname><given-names>JD</given-names></string-name>, <string-name><surname>Whelton</surname><given-names>PK</given-names></string-name>, <etal/>; <collab>SPRINT Research Group</collab></person-group>. <article-title>A randomized trial of intensive versus standard blood-pressure control</article-title>. <source>N Engl J Med</source>. <year>2015</year>;<volume>373</volume>(<issue>22</issue>):<fpage>2103</fpage>-<lpage>2116</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1511939</pub-id><?supplied-pmid 26551272?><pub-id pub-id-type="pmid">26551272</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Wright</surname><given-names>JT</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Whelton</surname><given-names>PK</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>KC</given-names></string-name>, <etal/>; <collab>SPRINT Research Group</collab></person-group>. <article-title>SPRINT revisited: updated results and implications</article-title>. <source>Hypertension</source>. <year>2021</year>;<volume>78</volume>(<issue>6</issue>):<fpage>1701</fpage>-<lpage>1710</lpage>. doi:<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.121.17682</pub-id><?supplied-pmid 34757768?><pub-id pub-id-type="pmid">34757768</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Nasrallah</surname><given-names>IM</given-names></string-name>, <string-name><surname>Pajewski</surname><given-names>NM</given-names></string-name>, <string-name><surname>Auchus</surname><given-names>AP</given-names></string-name>, <etal/>; <collab>SPRINT MIND Investigators for the SPRINT Research Group</collab></person-group>. <article-title>Association of intensive vs standard blood pressure control with cerebral white matter lesions</article-title>. <source>JAMA</source>. <year>2019</year>;<volume>322</volume>(<issue>6</issue>):<fpage>524</fpage>-<lpage>534</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2019.10551</pub-id><?supplied-pmid 31408137?><pub-id pub-id-type="pmid">31408137</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Nasrallah</surname><given-names>IM</given-names></string-name>, <string-name><surname>Gaussoin</surname><given-names>SA</given-names></string-name>, <string-name><surname>Pomponio</surname><given-names>R</given-names></string-name>, <etal/>; <collab>SPRINT Research Group</collab></person-group>. <article-title>Association of intensive vs standard blood pressure control with magnetic resonance imaging biomarkers of Alzheimer disease: secondary analysis of the SPRINT MIND randomized trial</article-title>. <source>JAMA Neurol</source>. <year>2021</year>;<volume>78</volume>(<issue>5</issue>):<fpage>568</fpage>-<lpage>577</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamaneurol.2021.0178</pub-id><?supplied-pmid 33683313?><pub-id pub-id-type="pmid">33683313</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Dolui</surname><given-names>S</given-names></string-name>, <string-name><surname>Detre</surname><given-names>JA</given-names></string-name>, <string-name><surname>Gaussoin</surname><given-names>SA</given-names></string-name>, <etal/></person-group>. <article-title>Association of intensive vs standard blood pressure control with cerebral blood flow: secondary analysis of the SPRINT MIND randomized clinical trial</article-title>. <source>JAMA Neurol</source>. <year>2022</year>;<volume>79</volume>(<issue>4</issue>):<fpage>380</fpage>-<lpage>389</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamaneurol.2022.0074</pub-id><?supplied-pmid 35254390?><pub-id pub-id-type="pmid">35254390</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Ambrosius</surname><given-names>WT</given-names></string-name>, <string-name><surname>Sink</surname><given-names>KM</given-names></string-name>, <string-name><surname>Foy</surname><given-names>CG</given-names></string-name>, <etal/>; <collab>SPRINT Study Research Group</collab></person-group>. <article-title>The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)</article-title>. <source>Clin Trials</source>. <year>2014</year>;<volume>11</volume>(<issue>5</issue>):<fpage>532</fpage>-<lpage>546</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1740774514537404</pub-id><?supplied-pmid 24902920?><pub-id pub-id-type="pmid">24902920</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Rapp</surname><given-names>SR</given-names></string-name>, <string-name><surname>Gaussoin</surname><given-names>SA</given-names></string-name>, <string-name><surname>Sachs</surname><given-names>BC</given-names></string-name>, <etal/>; <collab>SPRINT Research Group</collab></person-group>. <article-title>Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial</article-title>. <source>Lancet Neurol</source>. <year>2020</year>;<volume>19</volume>(<issue>11</issue>):<fpage>899</fpage>-<lpage>907</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(20)30319-7</pub-id><?supplied-pmid 33098800?><pub-id pub-id-type="pmid">33098800</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r31">
                <label>31</label>
                <mixed-citation publication-type="preprint"><person-group><string-name><surname>Doshi</surname><given-names>J</given-names></string-name>, <string-name><surname>Erus</surname><given-names>G</given-names></string-name>, <string-name><surname>Habes</surname><given-names>M</given-names></string-name>, <string-name><surname>Davatzikos</surname><given-names>C</given-names></string-name></person-group>. <article-title>DeepMRSeg: a convolutional deep neural network for anatomy and abnormality segmentation on MR images.</article-title><source>arXiv</source>. Preprint posted online July 3, 2019. doi:<pub-id pub-id-type="doi">10.48550/arXiv.1907.02110</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Jacobson</surname><given-names>AM</given-names></string-name>, <string-name><surname>Braffett</surname><given-names>BH</given-names></string-name>, <string-name><surname>Erus</surname><given-names>G</given-names></string-name>, <etal/>; <collab>DCCT/EDIC Research Group</collab></person-group>. <article-title>Brain structure among middle-aged and older adults with long-standing type 1 diabetes in the DCCT/EDIC Study</article-title>. <source>Diabetes Care</source>. <year>2022</year>;<volume>45</volume>(<issue>8</issue>):<fpage>1779</fpage>-<lpage>1787</lpage>. doi:<pub-id pub-id-type="doi">10.2337/dc21-2438</pub-id><?supplied-pmid 35699949?><pub-id pub-id-type="pmid">35699949</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Austin</surname><given-names>TR</given-names></string-name>, <string-name><surname>Nasrallah</surname><given-names>IM</given-names></string-name>, <string-name><surname>Erus</surname><given-names>G</given-names></string-name>, <etal/></person-group>. <article-title>Association of brain volumes and white matter injury with race, ethnicity, and cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis</article-title>. <source>J Am Heart Assoc</source>. <year>2022</year>;<volume>11</volume>(<issue>7</issue>):<elocation-id>e023159</elocation-id>. doi:<pub-id pub-id-type="doi">10.1161/JAHA.121.023159</pub-id><?supplied-pmid 35352569?><pub-id pub-id-type="pmid">35352569</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Austin</surname><given-names>TR</given-names></string-name>, <string-name><surname>Jensen</surname><given-names>PN</given-names></string-name>, <string-name><surname>Nasrallah</surname><given-names>IM</given-names></string-name>, <etal/></person-group>. <article-title>Left atrial function and arrhythmias in relation to small vessel disease on brain MRI: the Multi-Ethnic Study of Atherosclerosis</article-title>. <source>J Am Heart Assoc</source>. <year>2022</year>;<volume>11</volume>(<issue>20</issue>):<elocation-id>e026460</elocation-id>. doi:<pub-id pub-id-type="doi">10.1161/JAHA.122.026460</pub-id><?supplied-pmid 36250665?><pub-id pub-id-type="pmid">36250665</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Oishi</surname><given-names>K</given-names></string-name>, <string-name><surname>Faria</surname><given-names>A</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>H</given-names></string-name>, <etal/></person-group>. <article-title>Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer’s disease participants</article-title>. <source>Neuroimage</source>. <year>2009</year>;<volume>46</volume>(<issue>2</issue>):<fpage>486</fpage>-<lpage>499</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.01.002</pub-id><?supplied-pmid 19385016?><pub-id pub-id-type="pmid">19385016</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Basser</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Mattiello</surname><given-names>J</given-names></string-name>, <string-name><surname>LeBihan</surname><given-names>D</given-names></string-name></person-group>. <article-title>Estimation of the effective self-diffusion tensor from the NMR spin echo</article-title>. <source>J Magn Reson B</source>. <year>1994</year>;<volume>103</volume>(<issue>3</issue>):<fpage>247</fpage>-<lpage>254</lpage>. doi:<pub-id pub-id-type="doi">10.1006/jmrb.1994.1037</pub-id><?supplied-pmid 8019776?><pub-id pub-id-type="pmid">8019776</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Basser</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Mattiello</surname><given-names>J</given-names></string-name>, <string-name><surname>LeBihan</surname><given-names>D</given-names></string-name></person-group>. <article-title>MR diffusion tensor spectroscopy and imaging</article-title>. <source>Biophys J</source>. <year>1994</year>;<volume>66</volume>(<issue>1</issue>):<fpage>259</fpage>-<lpage>267</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0006-3495(94)80775-1</pub-id><?supplied-pmid 8130344?><pub-id pub-id-type="pmid">8130344</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Wu</surname><given-names>WC</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>SF</given-names></string-name>, <string-name><surname>Yang</surname><given-names>SC</given-names></string-name>, <string-name><surname>Lien</surname><given-names>SH</given-names></string-name></person-group>. <article-title>Pseudocontinuous arterial spin labeling perfusion magnetic resonance imaging—a normative study of reproducibility in the human brain</article-title>. <source>Neuroimage</source>. <year>2011</year>;<volume>56</volume>(<issue>3</issue>):<fpage>1244</fpage>-<lpage>1250</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.02.080</pub-id><?supplied-pmid 21385620?><pub-id pub-id-type="pmid">21385620</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yen</surname><given-names>YF</given-names></string-name>, <string-name><surname>Field</surname><given-names>AS</given-names></string-name>, <string-name><surname>Martin</surname><given-names>EM</given-names></string-name>, <etal/></person-group>. <article-title>Test-retest reproducibility of quantitative CBF measurements using FAIR perfusion MRI and acetazolamide challenge</article-title>. <source>Magn Reson Med</source>. <year>2002</year>;<volume>47</volume>(<issue>5</issue>):<fpage>921</fpage>-<lpage>928</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mrm.10140</pub-id><?supplied-pmid 11979571?><pub-id pub-id-type="pmid">11979571</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Binnie</surname><given-names>LR</given-names></string-name>, <string-name><surname>Pauls</surname><given-names>MMH</given-names></string-name>, <string-name><surname>Benjamin</surname><given-names>P</given-names></string-name>, <etal/></person-group>. <article-title>Test-retest reliability of arterial spin labelling for cerebral blood flow in older adults with small vessel disease</article-title>. <source>Transl Stroke Res</source>. <year>2022</year>;<volume>13</volume>(<issue>4</issue>):<fpage>583</fpage>-<lpage>594</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12975-021-00983-5</pub-id><?supplied-pmid 35080734?><pub-id pub-id-type="pmid">35080734</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Burbidge</surname><given-names>JB</given-names></string-name>, <string-name><surname>Magee</surname><given-names>L</given-names></string-name>, <string-name><surname>Robb</surname><given-names>AL</given-names></string-name></person-group>. <article-title>Alternative transformations to handle extreme values of the dependent variable</article-title>. <source>J Am Stat Assoc</source>. <year>1988</year>;<volume>83</volume>(<issue>401</issue>):<fpage>123</fpage>-<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1080/01621459.1988.10478575</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r42">
                <label>42</label>
                <mixed-citation publication-type="webpage">The R Foundation. The R project for statistical computing. Accessed January 25, 2023. <ext-link xlink:href="https://www.r-project.org/" ext-link-type="uri">https://www.r-project.org/</ext-link></mixed-citation>
              </ref>
              <ref id="zoi230061r43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Benjamini</surname><given-names>Y</given-names></string-name>, <string-name><surname>Hochberg</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source>J R Stat Soc B</source>. <year>1995</year>;<volume>57</volume>(<issue>1</issue>):<fpage>289</fpage>-<lpage>300</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.2517-6161.1995.tb02031.x</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>White</surname><given-names>WB</given-names></string-name>, <string-name><surname>Wakefield</surname><given-names>DB</given-names></string-name>, <string-name><surname>Moscufo</surname><given-names>N</given-names></string-name>, <etal/></person-group>. <article-title>Effects of intensive versus standard ambulatory blood pressure control on cerebrovascular outcomes in older people (INFINITY)</article-title>. <source>Circulation</source>. <year>2019</year>;<volume>140</volume>(<issue>20</issue>):<fpage>1626</fpage>-<lpage>1635</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.119.041603</pub-id><?supplied-pmid 31607143?><pub-id pub-id-type="pmid">31607143</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Markus</surname><given-names>HS</given-names></string-name>, <string-name><surname>Egle</surname><given-names>M</given-names></string-name>, <string-name><surname>Croall</surname><given-names>ID</given-names></string-name>, <etal/>; <collab>PRESERVE Study Team</collab></person-group>. <article-title>PRESERVE: randomized trial of intensive versus standard blood pressure control in small vessel disease</article-title>. <source>Stroke</source>. <year>2021</year>;<volume>52</volume>(<issue>8</issue>):<fpage>2484</fpage>-<lpage>2493</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.120.032054</pub-id><?supplied-pmid 34044580?><pub-id pub-id-type="pmid">34044580</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Dufouil</surname><given-names>C</given-names></string-name>, <string-name><surname>Chalmers</surname><given-names>J</given-names></string-name>, <string-name><surname>Coskun</surname><given-names>O</given-names></string-name>, <etal/>; <collab>PROGRESS MRI Substudy Investigators</collab></person-group>. <article-title>Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy</article-title>. <source>Circulation</source>. <year>2005</year>;<volume>112</volume>(<issue>11</issue>):<fpage>1644</fpage>-<lpage>1650</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.104.501163</pub-id><?supplied-pmid 16145004?><pub-id pub-id-type="pmid">16145004</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>de Havenon</surname><given-names>A</given-names></string-name>, <string-name><surname>Majersik</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Tirschwell</surname><given-names>DL</given-names></string-name>, <string-name><surname>McNally</surname><given-names>JS</given-names></string-name>, <string-name><surname>Stoddard</surname><given-names>G</given-names></string-name>, <string-name><surname>Rost</surname><given-names>NS</given-names></string-name></person-group>. <article-title>Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics</article-title>. <source>Neurology</source>. <year>2019</year>;<volume>92</volume>(<issue>11</issue>):<fpage>e1168</fpage>-<lpage>e1175</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000007093</pub-id><?supplied-pmid 30737332?><pub-id pub-id-type="pmid">30737332</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>de Leeuw</surname><given-names>FE</given-names></string-name>, <string-name><surname>de Groot</surname><given-names>JC</given-names></string-name>, <string-name><surname>Oudkerk</surname><given-names>M</given-names></string-name>, <etal/></person-group>. <article-title>Hypertension and cerebral white matter lesions in a prospective cohort study</article-title>. <source>Brain</source>. <year>2002</year>;<volume>125</volume>(<issue>pt 4</issue>):<fpage>765</fpage>-<lpage>772</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awf077</pub-id><?supplied-pmid 11912110?><pub-id pub-id-type="pmid">11912110</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Dufouil</surname><given-names>C</given-names></string-name>, <string-name><surname>de Kersaint-Gilly</surname><given-names>A</given-names></string-name>, <string-name><surname>Besançon</surname><given-names>V</given-names></string-name>, <etal/></person-group>. <article-title>Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI cohort</article-title>. <source>Neurology</source>. <year>2001</year>;<volume>56</volume>(<issue>7</issue>):<fpage>921</fpage>-<lpage>926</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.56.7.921</pub-id><?supplied-pmid 11294930?><pub-id pub-id-type="pmid">11294930</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name><surname>Liang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname><given-names>H</given-names></string-name>, <etal/></person-group>. <article-title>Structural changes in white matter lesion patients and their correlation with cognitive impairment</article-title>. <source>Neuropsychiatr Dis Treat</source>. <year>2019</year>;<volume>15</volume>:<fpage>1355</fpage>-<lpage>1363</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NDT.S194803</pub-id><?supplied-pmid 31190839?><pub-id pub-id-type="pmid">31190839</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Bartzokis</surname><given-names>G</given-names></string-name></person-group>. <article-title>Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease</article-title>. <source>Neurobiol Aging</source>. <year>2004</year>;<volume>25</volume>(<issue>1</issue>):<fpage>5</fpage>-<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2003.03.001</pub-id><?supplied-pmid 14675724?><pub-id pub-id-type="pmid">14675724</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Phillips</surname><given-names>OR</given-names></string-name>, <string-name><surname>Joshi</surname><given-names>SH</given-names></string-name>, <string-name><surname>Squitieri</surname><given-names>F</given-names></string-name>, <etal/></person-group>. <article-title>Major superficial white matter abnormalities in Huntington’s disease</article-title>. <source>Front Neurosci</source>. <year>2016</year>;<volume>10</volume>:<fpage>197</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnins.2016.00197</pub-id><?supplied-pmid 27242403?><pub-id pub-id-type="pmid">27242403</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Pierpaoli</surname><given-names>C</given-names></string-name>, <string-name><surname>Basser</surname><given-names>PJ</given-names></string-name></person-group>. <article-title>Toward a quantitative assessment of diffusion anisotropy</article-title>. <source>Magn Reson Med</source>. <year>1996</year>;<volume>36</volume>(<issue>6</issue>):<fpage>893</fpage>-<lpage>906</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mrm.1910360612</pub-id><?supplied-pmid 8946355?><pub-id pub-id-type="pmid">8946355</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Luque Laguna</surname><given-names>PA</given-names></string-name>, <string-name><surname>Combes</surname><given-names>AJE</given-names></string-name>, <string-name><surname>Streffer</surname><given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Reproducibility, reliability and variability of FA and MD in the older healthy population: a test-retest multiparametric analysis</article-title>. <source>Neuroimage Clin</source>. <year>2020</year>;<volume>26</volume>:<elocation-id>102168</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.nicl.2020.102168</pub-id><?supplied-pmid 32035272?><pub-id pub-id-type="pmid">32035272</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Alosco</surname><given-names>ML</given-names></string-name>, <string-name><surname>Gunstad</surname><given-names>J</given-names></string-name>, <string-name><surname>Xu</surname><given-names>X</given-names></string-name>, <etal/></person-group>. <article-title>The impact of hypertension on cerebral perfusion and cortical thickness in older adults</article-title>. <source>J Am Soc Hypertens</source>. <year>2014</year>;<volume>8</volume>(<issue>8</issue>):<fpage>561</fpage>-<lpage>570</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jash.2014.04.002</pub-id><?supplied-pmid 25151318?><pub-id pub-id-type="pmid">25151318</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Liao</surname><given-names>D</given-names></string-name>, <string-name><surname>Cooper</surname><given-names>L</given-names></string-name>, <string-name><surname>Cai</surname><given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control: the ARIC Study: Atherosclerosis Risk in Communities Study</article-title>. <source>Stroke</source>. <year>1996</year>;<volume>27</volume>(<issue>12</issue>):<fpage>2262</fpage>-<lpage>2270</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.STR.27.12.2262</pub-id><?supplied-pmid 8969791?><pub-id pub-id-type="pmid">8969791</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Basile</surname><given-names>AM</given-names></string-name>, <string-name><surname>Pantoni</surname><given-names>L</given-names></string-name>, <string-name><surname>Pracucci</surname><given-names>G</given-names></string-name>, <etal/>; <collab>LADIS Study Group</collab></person-group>. <article-title>Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes: the LADIS (Leukoaraiosis and Disability in the Elderly) Study</article-title>. <source>Cerebrovasc Dis</source>. <year>2006</year>;<volume>21</volume>(<issue>5-6</issue>):<fpage>315</fpage>-<lpage>322</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000091536</pub-id><?supplied-pmid 16490940?><pub-id pub-id-type="pmid">16490940</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Müller</surname><given-names>M</given-names></string-name>, <string-name><surname>Österreich</surname><given-names>M</given-names></string-name>, <string-name><surname>Lakatos</surname><given-names>L</given-names></string-name>, <string-name><surname>Hessling</surname><given-names>AV</given-names></string-name></person-group>. <article-title>Cerebral macro- and microcirculatory blood flow dynamics in successfully treated chronic hypertensive patients with and without white mater lesions</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>9213</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-020-66317-x</pub-id><?supplied-pmid 32514031?><pub-id pub-id-type="pmid">32514031</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Dunatov</surname><given-names>S</given-names></string-name>, <string-name><surname>Antoncic</surname><given-names>I</given-names></string-name>, <string-name><surname>Bralic</surname><given-names>M</given-names></string-name></person-group>. <article-title>Hemodynamic changes in the posterior cerebral circulation triggered by insufficient sympathetic innervation—cause of primary intracerebral hemorrhage?</article-title><source>Med Hypotheses</source>. <year>2011</year>;<volume>76</volume>(<issue>5</issue>):<fpage>668</fpage>-<lpage>669</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mehy.2011.01.027</pub-id><?supplied-pmid 21306832?><pub-id pub-id-type="pmid">21306832</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r60">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Tamayo</surname><given-names>A</given-names></string-name>, <string-name><surname>Siepmann</surname><given-names>T</given-names></string-name></person-group>. <article-title>Regulation of blood flow in the cerebral posterior circulation by parasympathetic nerve fibers: physiological background and possible clinical implications in patients with vertebrobasilar stroke</article-title>. <source>Front Neurol</source>. <year>2021</year>;<volume>12</volume>:<elocation-id>660373</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fneur.2021.660373</pub-id><pub-id pub-id-type="pmid">34777191</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r61">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Haubrich</surname><given-names>C</given-names></string-name>, <string-name><surname>Wendt</surname><given-names>A</given-names></string-name>, <string-name><surname>Diehl</surname><given-names>RR</given-names></string-name>, <string-name><surname>Klötzsch</surname><given-names>C</given-names></string-name></person-group>. <article-title>Dynamic autoregulation testing in the posterior cerebral artery</article-title>. <source>Stroke</source>. <year>2004</year>;<volume>35</volume>(<issue>4</issue>):<fpage>848</fpage>-<lpage>852</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.STR.0000120729.99039.B6</pub-id><?supplied-pmid 14988573?><pub-id pub-id-type="pmid">14988573</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r62">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sato</surname><given-names>K</given-names></string-name>, <string-name><surname>Fisher</surname><given-names>JP</given-names></string-name>, <string-name><surname>Seifert</surname><given-names>T</given-names></string-name>, <string-name><surname>Overgaard</surname><given-names>M</given-names></string-name>, <string-name><surname>Secher</surname><given-names>NH</given-names></string-name>, <string-name><surname>Ogoh</surname><given-names>S</given-names></string-name></person-group>. <article-title>Blood flow in internal carotid and vertebral arteries during orthostatic stress</article-title>. <source>Exp Physiol</source>. <year>2012</year>;<volume>97</volume>(<issue>12</issue>):<fpage>1272</fpage>-<lpage>1280</lpage>. doi:<pub-id pub-id-type="doi">10.1113/expphysiol.2012.064774</pub-id><?supplied-pmid 22689443?><pub-id pub-id-type="pmid">22689443</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r63">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sato</surname><given-names>K</given-names></string-name>, <string-name><surname>Sadamoto</surname><given-names>T</given-names></string-name>, <string-name><surname>Hirasawa</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Differential blood flow responses to CO<sub>2</sub> in human internal and external carotid and vertebral arteries</article-title>. <source>J Physiol</source>. <year>2012</year>;<volume>590</volume>(<issue>14</issue>):<fpage>3277</fpage>-<lpage>3290</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.2012.230425</pub-id><?supplied-pmid 22526884?><pub-id pub-id-type="pmid">22526884</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r64">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Nakagawa</surname><given-names>K</given-names></string-name>, <string-name><surname>Serrador</surname><given-names>JM</given-names></string-name>, <string-name><surname>Larose</surname><given-names>SL</given-names></string-name>, <string-name><surname>Moslehi</surname><given-names>F</given-names></string-name>, <string-name><surname>Lipsitz</surname><given-names>LA</given-names></string-name>, <string-name><surname>Sorond</surname><given-names>FA</given-names></string-name></person-group>. <article-title>Autoregulation in the posterior circulation is altered by the metabolic state of the visual cortex</article-title>. <source>Stroke</source>. <year>2009</year>;<volume>40</volume>(<issue>6</issue>):<fpage>2062</fpage>-<lpage>2067</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.108.545285</pub-id><?supplied-pmid 19359628?><pub-id pub-id-type="pmid">19359628</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r65">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Washio</surname><given-names>T</given-names></string-name>, <string-name><surname>Watanabe</surname><given-names>H</given-names></string-name>, <string-name><surname>Ogoh</surname><given-names>S</given-names></string-name></person-group>. <article-title>Dynamic cerebral autoregulation in anterior and posterior cerebral circulation during cold pressor test</article-title>. <source>J Physiol Sci</source>. <year>2020</year>;<volume>70</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1186/s12576-020-00732-7</pub-id><?supplied-pmid 32039699?><pub-id pub-id-type="pmid">32039699</pub-id></mixed-citation>
              </ref>
              <ref id="zoi230061r66">
                <label>66</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Nobili</surname><given-names>F</given-names></string-name>, <string-name><surname>Rodriguez</surname><given-names>G</given-names></string-name>, <string-name><surname>Marenco</surname><given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Regional cerebral blood flow in chronic hypertension: a correlative study</article-title>. <source>Stroke</source>. <year>1993</year>;<volume>24</volume>(<issue>8</issue>):<fpage>1148</fpage>-<lpage>1153</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.STR.24.8.1148</pub-id><?supplied-pmid 8342188?><pub-id pub-id-type="pmid">8342188</pub-id></mixed-citation>
              </ref>
            </ref-list>
            <notes notes-type="supplementary-material" id="note-ZOI230061-1">
              <supplementary-material id="note-ZOI230061-1-s" position="float" content-type="local-data">
                <label>Supplement 1.</label>
                <caption>
                  <p>
Trial Protocol
</p>
                </caption>
                <media xlink:href="jamanetwopen-e231055-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material position="float" content-type="local-data">
                <label>Supplement 2.</label>
                <caption>
                  <p><bold>eTable 1.</bold> SPRINT MRI Scanner Parameters</p>
                  <p>
eMethods 1.
</p>
                  <p>
eResults 1.
</p>
                  <p><bold>eTable 2.</bold> Baseline Characteristics of Participants in MRI Substudy vs Remaining Trial Participants</p>
                  <p><bold>eTable 3.</bold> Characteristics of Participants in MRI Substudy Who Had Both Baseline and Follow-up Scans</p>
                  <p><bold>eResults 2.</bold> Superficially Located WM (SWM)</p>
                  <p><bold>eFigure.</bold> Patterns of Changes in the Type III White Matter Parcellation Map (WMPM) Derived Deep White Matter Regions-of-Interest (ROIs) When Comparing Intensive Treatment Group With Standard Treatment Group</p>
                  <p><bold>eTable 4.</bold> Changes in White Matter Lesions (WML) Derived in Deep White Matter (DWM) Regions-of-Interest (ROIs) Between Intensive Treatment Group and Standard Treatment Group</p>
                  <p><bold>eTable 5.</bold> Changes in White Matter Lesions (WML) Derived in Superficially-Located White Matter (SWM) Regions-of-Interest (ROIs) Between Intensive Treatment Group and Standard Treatment Group</p>
                  <p><bold>eTable 6.</bold> Changes in Diffusion Tensor Imaging (DTI) Fractional Anisotropy (FA) Derived in Deep White Matter (DWM) Regions-of-Interest (ROIs) Between Intensive Treatment Group and Standard Treatment Group</p>
                  <p><bold>eTable 7.</bold> Changes in Diffusion Tensor Imaging (DTI) Fractional Anisotropy (FA) Derived in Superficially-Located White Matter (SWM) Regions-of-Interest (ROIs) Between Intensive Treatment Group and Standard Treatment Group</p>
                  <p><bold>eTable 8.</bold> Changes in Diffusion Tensor Imaging (DTI) Mean Diffusivity (MD) Derived in Deep White Matter (DWM) Regions-of-Interest (ROIs) Between Intensive Treatment Group and Standard Treatment Group</p>
                  <p><bold>eTable 9.</bold> Changes in Diffusion Tensor Imaging (DTI) Mean Diffusivity (MD) Derived in Superficially-Located White Matter (SWM) Regions-of-Interest (ROIs) Between Intensive Treatment Group and Standard Treatment Group</p>
                  <p><bold>eTable 10.</bold> Changes in Cerebral Blood Flow (CBF) Derived in Gray Matter (GM) Regions-of-Interest (ROIs) Between Intensive Treatment Group and Standard Treatment Group</p>
                  <p><bold>eMethods 2.</bold> Multiple Imputation</p>
                  <p><bold>eTable 11.</bold> Condition Model for Multiple Imputation</p>
                  <p><bold>eTable 12.</bold> Changes in White Matter Lesions (WML) Derived in Deep White Matter (DWM) Regions-of-Interest (ROIs) Between Intensive Treatment Group and Standard Treatment Group After Multiple Imputation</p>
                  <p>
eReferences.
</p>
                </caption>
                <media xlink:href="jamanetwopen-e231055-s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material position="float" content-type="local-data">
                <label>Supplement 3.</label>
                <caption>
                  <p>
Data Sharing Statement
</p>
                </caption>
                <media xlink:href="jamanetwopen-e231055-s003.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </notes>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
